Cytarabine

Chemotherapy

Brand names:

Cytosar-U®, Depocyt®

Other names:

Ara-C, Cytosine arabinoside

Often used for:

Leukemias, Lymphomas

About Cytarabine

Cytarabine is a type of chemotherapy. It works by slowing or stopping the growth of cancer cells. It is usually used in combination with other drugs.

Patients will have regular blood draws to check blood counts and monitor liver and kidney function.

May be given as a liquid into a vein by IV

May be given as a liquid under the skin (subcutaneous)

May be given in the cerebrospinal fluid (intrathecal)

Possible Side Effects

Mouth sores
Sore or red eyes
Skin rash
Fever
Nausea and vomiting
Diarrhea
Loss of appetite
Abdominal pain
Hair loss
Muscle or joint pain
Tiredness
Skin irritation at the IV site
Headaches (after intrathecal delivery)
Yellowing of the skin or eyes
Seizures
Confusion
Numbness, burning, or tingling in arms and legs

Symptoms of an allergic reaction may include: rash, hives, itching, chills, fever, headache, muscle ache, shortness of breath, coughing, tightness in the throat, swelling of the face or neck.

Not all patients who take cytarabine will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.

Possible Late Effects

Some patients may experience long-term or late effects of treatment that may continue or develop months or years after treatment ends. Possible late effects due to cytarabine include:

Cognitive problems
Changes in behavior
Neurologic disorder called ‘leukoencephalopathy’. Signs may include confusion, weakness, difficulty speaking, vision changes, or seizures.

Tips for Families

Be sure to discuss these and other recommendations with your doctor or pharmacist.

A doctor may prescribe medicine to reduce nausea and vomiting.
A doctor may recommend eye drops to help decrease sore or red eyes – make sure to use as directed.
Sexually active patients should take steps to prevent pregnancy during treatment and for 6 months after completion of therapy.
Patients should tell their doctor if they are pregnant or breastfeeding.
Caregivers should follow instructions to avoid contact with patient body fluids, which can contain the drug for 48 hours after it is given.

Cytarabine resources

Learn More About Cytarabine

Print This Page

Always check the medication label. Many medicines look the same. Do not take any new medicine, including over-the counter medicines or supplements, without checking with your doctor or pharmacist. Talk to your doctor or pharmacist about what to do in the case of a missed dose, allergic reaction, or medical emergency.

This information is not intended to be a complete guide and is not a substitute for talking with your provider. Medicine names, appearance, formulas, or availability may vary by clinic location. Always follow the instructions given by your care team.